{
    "prompt": "\n    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n    {\n        \"Status\": \"no_match\",\n        \"Message\": \"No drugs are FDA-approved for the provided context\"\n    }\n    \n    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n    {\n        \"Status\": \"success\",\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\": \n            \"FDA-approval status\":\n            \"Link to FDA-approved Label\":\n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0018760\nAge: 30\nGender: Female\nSample ID: P-0018760-T01-IM6\nGene Panel: IMPACT468\nCancer Type: Rectal Adenocarcinoma\nSample Type: Primary\nTumor Purity: 20.0%\n=============\nDNA Variants:\nAPC c.1690C>T (p.R564*) - in 17.00% of 197 reads\nERBB4 c.836T>G (p.F279C) - in 8.00% of 237 reads\nPTPRS c.2566G>T (p.A856S) - in 18.00% of 573 reads\nTP53 c.527G>T (p.C176F) - in 11.00% of 646 reads\nTP53 c.702C>G (p.Y234*) - in 25.00% of 638 reads\nCNA Data:\nERBB2 - High Level Amplification\nCDK12 - High Level Amplification\nRARA - High Level Amplification\nStructural Variants:\nNo structural variant data found.\n    ",
    "response": "{\n  \"Status\": \"no_match\",\n  \"Message\": \"No drugs are FDA-approved for the provided context\"\n}"
}